Merck KGaA

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: DE0006599905
EUR
119.40
2.65 (2.27%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

286.38 k

Shareholding (Dec 2023)

FII

0.01%

Held by 6 FIIs

DII

99.99%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

High Management Efficiency with a high ROCE of 13.62%

 
2

Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 14.04

 
3

High Debt company with Weak Long Term Fundamental Strength

 
4

With ROE of 10.90%, it has a Very Attractive valuation with a 1.73 Price to Book Value

5

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

EUR 51,912 Million ()

stock-summary
P/E

16.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.30

stock-summary
Return on Equity

11.08%

stock-summary
Price to Book

1.79

Revenue and Profits:
Net Sales:
5,255 Million
(Quarterly Results - Jun 2025)
Net Profit:
655 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
8.94%
0%
8.94%
6 Months
3.78%
0%
3.78%
1 Year
-16.15%
0%
-16.15%
2 Years
-24.86%
0%
-24.86%
3 Years
-32.68%
0%
-32.68%
4 Years
-44.1%
0%
-44.1%
5 Years
-13.1%
0%
-13.1%

Merck KGaA for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
4.20%
EBIT Growth (5y)
8.73%
EBIT to Interest (avg)
14.04
Debt to EBITDA (avg)
1.36
Net Debt to Equity (avg)
0.26
Sales to Capital Employed (avg)
0.59
Tax Ratio
21.40%
Dividend Payout Ratio
34.44%
Pledged Shares
0
Institutional Holding
0.02%
ROCE (avg)
13.62%
ROE (avg)
13.24%
Valuation key factors
Factor
Value
P/E Ratio
16
Industry P/E
Price to Book Value
1.73
EV to EBIT
12.37
EV to EBITDA
8.68
EV to Capital Employed
1.57
EV to Sales
2.65
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
12.74%
ROE (Latest)
10.89%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
Bullish
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2023stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 6 Foreign Institutions (0.01%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -0.47% vs -2.55% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -11.25% vs 10.31% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5,255.00",
          "val2": "5,280.00",
          "chgp": "-0.47%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,534.00",
          "val2": "1,650.00",
          "chgp": "-7.03%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "79.00",
          "val2": "78.00",
          "chgp": "1.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-93.00",
          "val2": "-51.00",
          "chgp": "-82.35%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "655.00",
          "val2": "738.00",
          "chgp": "-11.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "204.90%",
          "val2": "222.90%",
          "chgp": "-1.80%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.78% vs -5.57% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -1.69% vs -15.12% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "21,156.00",
          "val2": "20,993.00",
          "chgp": "0.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "6,168.00",
          "val2": "5,825.00",
          "chgp": "5.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "211.00",
          "val2": "255.00",
          "chgp": "-17.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-674.00",
          "val2": "-471.00",
          "chgp": "-43.10%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,786.00",
          "val2": "2,834.00",
          "chgp": "-1.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "206.20%",
          "val2": "192.60%",
          "chgp": "1.36%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
5,255.00
5,280.00
-0.47%
Operating Profit (PBDIT) excl Other Income
1,534.00
1,650.00
-7.03%
Interest
79.00
78.00
1.28%
Exceptional Items
-93.00
-51.00
-82.35%
Consolidate Net Profit
655.00
738.00
-11.25%
Operating Profit Margin (Excl OI)
204.90%
222.90%
-1.80%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is -0.47% vs -2.55% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -11.25% vs 10.31% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
21,156.00
20,993.00
0.78%
Operating Profit (PBDIT) excl Other Income
6,168.00
5,825.00
5.89%
Interest
211.00
255.00
-17.25%
Exceptional Items
-674.00
-471.00
-43.10%
Consolidate Net Profit
2,786.00
2,834.00
-1.69%
Operating Profit Margin (Excl OI)
206.20%
192.60%
1.36%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 0.78% vs -5.57% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -1.69% vs -15.12% in Dec 2023

stock-summaryCompany CV
About Merck KGaA stock-summary
stock-summary
Merck KGaA
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available